All articles by Srivani Venna

  1. Healthcare sector witnesses growth in deal activity despite Covid-19 concerns

    A total of 152 deals were announced in the global healthcare sector, including pharmaceuticals and medical equipment, during the week…
    Read More…

    3 Apr
  2. Asia-Pacific deal activity drops 18.6% due to coronavirus

    A total of 215 deals were announced in the Asia-Pacific (APAC) region during the week ended 29 March 2020, according…
    Read More…

    1 Apr
  3. Global deal activity decreases 19.7% over coronavirus fears

    A total of 837 deals were announced globally during the week ended 29 March 2020, according to GlobalData’s deals database….
    Read More…

    1 Apr
  4. Vir Biotechnology and Alnylam partner in fight against Covid-19

    Clinical-stage immunology firm Vir Biotechnology and biopharmaceutical company Alnylam Pharmaceuticals have extended their existing partnership to advance RNAi therapeutics to…
    Read More…

    5 Mar
  5. Takeda to start drug development for coronavirus treatment

    Follow the latest updates of the outbreak on our timeline. Takeda Pharmaceutical Company is set to start the development of a drug to…
    Read More…

    5 Mar
  6. Roche wins approval for Actemra for coronavirus complications

    Follow the latest updates of the outbreak on our timeline. Swiss healthcare company Roche has secured approval from China for its anti-inflammation drug…
    Read More…

    5 Mar
  7. Takeda to sell select non-core assets in Latin America for $825m

    Takeda Pharmaceutical has agreed to sell a portfolio of select non-core products exclusively in Latin America to Brazilian firm Hypera…
    Read More…

    3 Mar
  8. Gilead Sciences to purchase Forty Seven for $4.9bn

    Research-based biopharmaceutical company Gilead Sciences has agreed to acquire clinical-stage immuno-oncology firm Forty Seven for $4.9bn. Gilead will buy Forty…
    Read More…

    3 Mar
  9. FDA approves Cumberland’s methotrexate products line

    The US Food and Drug Administration (FDA) has approved Cumberland Pharmaceuticals’ methotrexate products to treat adult and paediatric patients with…
    Read More…

    3 Dec
  10. Chidamide gets approval in China for breast cancer indication

    Drug development company Chipscreen Biosciences’ oral subtype-selective histone deacetylase (HDAC) inhibitor, Epidaza (Chidamide), has secured approval in China for its…
    Read More…

    2 Dec
Close
Close
Close

Go Top